Cranial Implants Market Forecast to 2031: Global Analysis by Type, End User, and Geography

Our latest research study on the Cranial Implants Market indicates a promising growth trajectory, with projections estimating an increase from US$ 1,429.14 million in 2023 to US$ 2,443.48 million by 2031. This growth represents a compound annual growth rate (CAGR) of 6.9% during the period from 2023 to 2031. The rising incidence of traumatic brain injuries (TBIs) and the expanding elderly demographic are significant factors driving the growth of the cranial implants market. However, the potential for implant failure poses a challenge to market expansion. Additionally, the emergence of customized implants is expected to shape new trends in the cranial implants sector in the years ahead.

Regional Insights

In terms of revenue, North America led the cranial implants market in 2023 and is projected to maintain its dominance throughout the forecast period. The United States stands out as the largest market globally for cranial implants. TBIs are a leading cause of mortality and emergency room visits in the US. According to data from the Centers for Disease Control and Prevention (CDC), over 69,000 TBI-related deaths were reported in 2021, averaging approximately 190 deaths per day. Furthermore, in 2020, there were around 214,110 TBI-related hospitalizations in the country. TBIs are significant contributors to cranial deformities, necessitating surgical interventions with implants, thereby increasing the demand for cranial implants.

Moreover, statistics from Johns Hopkins University reveal that approximately 30 million children and adolescents engage in sports in the US, with over 3.5 million children aged 14 or younger experiencing sports-related injuries annually. Such injuries, along with falls, are common causes of TBIs, further driving the demand for cranial implants for surgical reconstruction.

Recent Developments in Cranial Implants

In April 2024, 3D Systems received FDA 510(k) clearance for its VSP PEEK Cranial Implant. This innovative additive manufacturing solution enables the production of patient-specific cranial implants while utilizing up to 85% less material compared to traditional machining methods, resulting in substantial cost savings on high-value raw materials like implantable PEEK. Additionally, in the same month, Longeviti Neuro Solutions, a neurotechnology firm based in Maryland, obtained a US patent for its ClearFit prosthetic translucent cranial implant, designed for use in neurosurgical procedures.

Market Analysis: 3D Printing Advancements

The integration of 3D printing, or additive manufacturing, into the cranial implants market presents significant opportunities for future growth. This technology facilitates the creation of highly customized, patient-specific cranial implants that enhance fit and functionality compared to conventional implants. The evolution of cranial implant design and production has been significantly influenced by advancements in 3D printing, allowing for precise replication of individual skull geometries, which minimizes surgical complications and improves recovery outcomes.

The incorporation of multilayer technology in 3D printing further amplifies these advantages. This technology enables the fabrication of implants with multiple layers, each engineered with distinct properties tailored for specific functions. For example, one layer may be designed for structural integrity, while another focuses on biocompatibility or flexibility. Such multilayered 3D-printed implants can enhance osseointegration (the process of bone growth into the implant), lower the risk of implant rejection, and provide superior protection for the brain.

3D printing also allows for expedited production times, reduced manufacturing costs, and greater adaptability to complex cranial deformities. These advancements not only enhance patient outcomes but also lower overall treatment costs, making cranial implants more accessible to a wider patient demographic. Consequently, the advancements in 3D printing, particularly with the integration of original multilayer technology, present substantial opportunities for the cranial implants market, offering improved surgical precision, reduced complications, and enhanced long-term performance.

Market Segmentation Analysis

The cranial implants market can be segmented based on type, material, and end user:

• Type: The market is divided into parietal, frontal, occipital, temporal, and sphenoid segments. The parietal segment held the largest market share in 2023.


• Material: The market is categorized into polymethyl methacrylate, porous polyethylene, and titanium, with polymethyl methacrylate dominating in 2023.


• End User: The market is segmented into hospitals, trauma centers, and ambulatory surgical centers, with hospitals leading the market in 2023.

Competitive Landscape and Key Players

Key players in the cranial implants market include Evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, EUROS SAS, GPC Medical Ltd, Bioplate Inc, 3D Systems Corp, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, and Johnson & Johnson.

The cranial implants market report is based on comprehensive research, utilizing primary and secondary sources, including the Bolt Burdon Kemp 2024 report, Government of Canada, Head Injuries in Australia Report, World Health Organization, and the Brain Injury Association of Waterloo-Wellington.